Tower Research Capital (TRC)’s Aptose Biosciences APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-6
Closed -$526 – 6399
2023
Q3
$526 Buy
6
+5
+500% +$589 ﹤0.01% 5542
2023
Q2
$135 Buy
+1
New +$207 ﹤0.01% 5782
2022
Q4
– Sell
-20
Closed -$5K – 6681
2022
Q3
$5K Buy
20
+4
+25% +$1.38K ﹤0.01% 5202
2022
Q2
$5K Buy
+16
New +$7.65K ﹤0.01% 5141
2022
Q1
– Sell
-14
Closed -$9K – 6886
2021
Q4
$9K Sell
14
-42
-75% -$39.5K ﹤0.01% 4752
2021
Q3
$54K Buy
+56
New +$70K ﹤0.01% 2907
2020
Q4
– Sell
-1
Closed -$3K – 5498
2020
Q3
$3K Sell
1
-18
-95% -$44.9K ﹤0.01% 4541
2020
Q2
$55K Buy
19
+7
+58% +$22.6K ﹤0.01% 2975
2020
Q1
$32K Buy
+12
New +$35.8K ﹤0.01% 1499
2019
Q4
– Sell
-2
Closed -$2K – 4617
2019
Q3
$2K Hold
2
– – ﹤0.01% 3769
2019
Q2
$2K Buy
+2
New +$1.84K ﹤0.01% 3348
2018
Q4
– Sell
-5
Closed -$6K – 4523
2018
Q3
$6K Buy
5
+3
+150% +$4.02K ﹤0.01% 3069
2018
Q2
$3K Buy
+2
New +$3.19K ﹤0.01% 3270
2018
Q1
– Hold
0
– – – 4013
2017
Q4
– Sell
-4
Closed -$3.09K – 4181
2017
Q3
$4K Sell
4
-2
-33% -$1.34K ﹤0.01% 3427
2017
Q2
$4K Buy
+6
New +$2.89K ﹤0.01% 2144
2017
Q1
– Sell
-2
Closed -$1.02K – 4138
2016
Q4
$2K Buy
+2
New +$1.24K ﹤0.01% 3494
2016
Q3
– Sell
-2
Closed -$2.08K – 4683
2016
Q2
$3K Hold
2
– – ﹤0.01% 3766
2016
Q1
$2K Sell
2
-2
-50% -$2.39K ﹤0.01% 3487
2015
Q4
$4K Sell
4
-18
-82% -$31.8K ﹤0.01% 3288
2015
Q3
$43K Sell
22
-4
-15% -$8.9K ﹤0.01% 1131
2015
Q2
$59K Buy
26
+8
+44% +$20.9K 0.01% 1242
2015
Q1
$44K Buy
18
+6
+50% +$14.5K 0.01% 1583
2014
Q4
$31K Buy
+12
New +$36.1K ﹤0.01% 1317

Other funds holding APTO

Tower Research Capital (TRC)'s APTO Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Aptose Biosciences (APTO) in Q4 2023, closing a stake of 6 shares — an estimated $526 sold.

Tower Research Capital (TRC) first reported a position in APTO in Q4 2014 and held it in 23 quarters. The position peaked at $59K in Q2 2015. 25 funds tracked by Wall St. Rank hold APTO as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Aptose Biosciences position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6 Aptose Biosciences shares in Q4 2023, an estimated $526.
  • Tower Research Capital (TRC) first reported a position in Aptose Biosciences in Q4 2014 and held it in 23 quarters.
  • Tower Research Capital (TRC)'s Aptose Biosciences position peaked at $59K in Q2 2015.
  • 25 funds tracked by Wall St. Rank held Aptose Biosciences as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.